Showing results (21-30 of 261) with videos related to
Sort By:
Pageof 27
Journal of Cancer Research and Clinical Oncology|December 13, 2019
The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastasesRui Kitadai, Yusuke Okuma, Taiki Hakozaki, et al.Oncology Letters|October 9, 2014
Clinical outcome of thymic lymphoepithelioma-like carcinoma: Case report of a 14-year-old maleKuniko Sekihara, Yusuke Okuma, Hiroshi Kawamoto, et al.Cancer Immunology, Immunotherapy : CII|December 16, 2017
High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancerYusuke Okuma, Tsunekazu Hishima, Jumpei Kashima, et al.Cancer Immunology, Immunotherapy : CII|August 8, 2018
Correction to: High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancerYusuke Okuma, Tsunekazu Hishima, Jumpei Kashima, et al.Cancer Immunology, Immunotherapy : CII|September 16, 2017
Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case reportJumpei Kashima, Yusuke Okuma, Ryoko Shimizuguchi, et al.Journal of Cancer Research and Clinical Oncology|July 28, 2019
Correlation between the qualification for bevacizumab use and the survival of patients with non-small cell lung cancer harboring the epidermal growth factor receptor mutation: a retrospective analysisTaiki Hakozaki, Yusuke Okuma, Kana Hashimoto, et al.Oncology|July 16, 2019
Radiographic Assessment of Objective Responses Using the ITMIG-Modified Criteria in Thymic CarcinomaTaiki Hakozaki, Yusuke Okuma, Yukio Hosomi, et al.Oncology|February 26, 2020
High Serum OX40 and OX40 Ligand (OX40L) Levels Correlate with Reduced Survival in Patients with Advanced Lung AdenocarcinomaJumpei Kashima, Yusuke Okuma, Yukio Hosomi, et al.BMC Cancer|September 8, 2016
Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature reviewKana Hashimoto, Yusuke Okuma, Yukio Hosomi, et al.Medical Oncology (Northwood, London, England)|October 21, 2016
Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitorsJumpei Kashima, Yusuke Okuma, Maki Miwa, et al.Pageof 27